Laparoscopic D2 lymphadenectomy

PROCEDURE3 trials

Sponsors

Huazhong University of Science and Technology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Fujian Medical University

Conditions

Gastric CancerGastric Cancer Stage IIGastric Cancer Stage IIIStomach Neoplasm

Phase 2

Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric Cancer

Fujian Medical UniversityStomach Neoplasm

Start: 2017-08-01End: 2023-08-31Target: 160Updated: 2020-02-05

Unknown Phase

Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision（D2+CME）for Advanced Gastric Cancer

Huazhong University of Science and TechnologyGastric Cancer

Start: 2014-09-30End: 2023-10-31Target: 169Updated: 2020-04-10

Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer

Guangdong Provincial Hospital of Traditional Chinese MedicineGastric Cancer Stage II, Gastric Cancer Stage III

Start: 2016-11-30End: 2024-11-30Target: 100Updated: 2016-11-21

Related Papers

The Use of <scp>CellCollector</scp> Assay to Detect Free Cancer Cells in the Peritoneal Cavity of Colorectal Cancer Patients: An Experimental Study

Cancer Medicine2024-11-011 citations

The number of mesogastria containing metastatic lymph nodes predicts gastric cancer prognosis.

2024-06-15

Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study)

British journal of surgery2024-05-014 citations

De-identified IPD for "Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial (NCT01978444)"

Data Archiving and Networked Services (DANS)2021-02-01

Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.

2018-08-0911 citations

Morbidity and mortality of laparoscopic D2 gastrectomy with complete mesogastrium excision (D2+CME) versus conventional D2 gastrectomy for advanced gastric cancer: An interim report of a single-center, prospective, randomized trial (NCT01978444).

Journal of Clinical Oncology2018-02-01

Laparoscopic D2 gastrectomy with complete mesogastrium excision (D2+CME) to reduce cancer leak from mesogastrium in patients with advanced gastric cancer.

Journal of Clinical Oncology2017-02-01

Short-term outcomes of laparoscopic D2 gastrectomy with complete mesogastrium excision (D2+CME) for advanced gastric cancer.

Journal of Clinical Oncology2017-02-01